Biohit Oyj

Board/Management Information • May 4, 2017

Disclosure 352055

Biohit Oyj - Changes board/management/auditors

Lea Paloheimo appointed Biohit Oyj’s R&D and production director

Biohit Oyj Changes board/management/ auditors May 4, 2017 at 10:00 a.m. local time (EEST) Lea Paloheimo, PhD (clinical biochemistry), has been appointed Biohit Oyj’s R&D and production director. Lea Paloheimo has been a member of the Biohit Oyj’s management team since 2006. CEO Semi Korpela, Biohit Oyj: ‘Lea Paloheimo has over fifteen years of experience in various positions in Biohit Oyj.’ Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com